Why are clinical trials of glucosamine no longer uniformly positive? (Q35578069)

9 August 2017

title

Why are clinical trials of glucosamine no longer uniformly positive? (English)

1 reference

9 August 2017

0 references

Tim McAlindon

1

1 reference

9 August 2017

publication date

1 November 2003

1 reference

Rheumatic Diseases Clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

29

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

789-801

1 reference

The neglect of glucosamine as a treatment for osteoarthritis--a personal perspective

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

A method for assessing the quality of a randomized control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Glucosamine sulfate in osteoarthritis of the knee.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Effect of alignment of the medial tibial plateau and X-ray beam on apparent progression of osteoarthritis in the standing anteroposterior knee radiograph

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Contribution of meniscal extrusion and cartilage loss to joint space narrowing in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Associations of radiological osteoarthritis of the hip and knee with locomotor disability in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Glusoamine for osteoarthritis: dawn of a new era?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Do certain countries produce only positive results? A systematic review of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Regulation of "nutraceuticals"

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

Sulfate could mediate the therapeutic effect of glucosamine sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900064-4

7 January 2021

10.1016/S0889-857X(03)00064-4

Identifiers

DOI

1 reference

9 August 2017

1 reference